Compounds > azacitidine

azacitidine and dinoprostone

azacitidine has been researched along with dinoprostone in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fukui, T; Furusho, K; Heike, T; Iio, J; Katamura, K; Kiyomasu, T; Mayumi, M; Tai, G; Ueno, H1
Fu, HY; Hori, M; Kawano, S; Murata, H; Sakaguchi, Y; Tsuji, S; Tsujii, M1
Ganesan, A; Haglund, C; Hemmes, A; Junnila, S; Kokkola, A; Monni, O; Mrena, J; Nykänen, A; Petrova, TV; Ristimäki, A; Tai, HH; Thiel, A1
Li, P; Meng, XY; Wang, YJ; Zhang, ST; Zhu, ST; Zong, Y1
Ardekani, AM; Jeddi Tehrani, M; Soleymani Fard, S1
Katiyar, SK; Prasad, R1
Kim, SJ; Yu, SM1

Other Studies

8 other study(ies) available for azacitidine and dinoprostone

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
IL-4 and prostaglandin E2 inhibit hypomethylation of the 5' regulatory region of IFN-gamma gene during differentiation of naive CD4+ T cells.
    Molecular immunology, 1998, Volume: 35, Issue:1

    Topics: Azacitidine; CD4-Positive T-Lymphocytes; Cell Differentiation; Dinoprostone; DNA Methylation; Fetal Blood; Humans; Interferon-gamma; Interleukin-4; Introns; Receptors, Antigen, T-Cell, alpha-beta; Regulatory Sequences, Nucleic Acid

1998
Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells.
    Laboratory investigation; a journal of technical methods and pathology, 2004, Volume: 84, Issue:8

    Topics: Azacitidine; Base Sequence; Carcinoma, Hepatocellular; Cell Division; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Decitabine; Dinoprostone; DNA Methylation; DNA, Neoplasm; Gene Silencing; Humans; Isoenzymes; Liver Neoplasms; Membrane Proteins; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases

2004
15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jul-15, Volume: 15, Issue:14

    Topics: Azacitidine; Cell Line, Tumor; Cell Proliferation; CpG Islands; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Decitabine; Dinoprostone; DNA Methylation; Down-Regulation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydroxyprostaglandin Dehydrogenases; Immunohistochemistry; Interleukin-1beta; Nitrobenzenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Stomach Neoplasms; Sulfonamides; Transfection

2009
Promoter hypermethylation of cyclooxygenase-2 gene in esophageal squamous cell carcinoma.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2011, Volume: 24, Issue:6

    Topics: Azacitidine; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclooxygenase 2; Decitabine; Dinoprostone; DNA Methylation; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Promoter Regions, Genetic; RNA, Messenger; Sequence Analysis, DNA

2011
Prostaglandin E2 induces growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6).
    Prostaglandins, leukotrienes, and essential fatty acids, 2012, Volume: 87, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Azacitidine; Caspase 3; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Decitabine; Dinoprostone; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

2012
Prostaglandin E2 Promotes UV radiation-induced immune suppression through DNA hypermethylation.
    Neoplasia (New York, N.Y.), 2013, Volume: 15, Issue:7

    Topics: Animals; Azacitidine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dermatitis, Contact; Dinoprostone; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Activation; Female; Gene Expression Regulation; Immune Tolerance; Male; Mice; Mice, Knockout; Radiation Tolerance; Receptors, Prostaglandin E, EP2 Subtype; Sp1 Transcription Factor; Sp3 Transcription Factor; Ultraviolet Rays

2013
DNA-hypomethylating agent, 5'-azacytidine, induces cyclooxygenase-2 expression via the PI3-kinase/Akt and extracellular signal-regulated kinase-1/2 pathways in human HT1080 fibrosarcoma cells.
    International journal of oncology, 2015, Volume: 47, Issue:4

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Fibrosarcoma; Fluorescent Antibody Technique; Humans; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction

2015